| Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Heat-Shock Proteins | 64 | 2023 | 822 | 12.340 |
Why?
|
| HSP70 Heat-Shock Proteins | 58 | 2023 | 404 | 10.020 |
Why?
|
| Molecular Chaperones | 37 | 2023 | 743 | 6.670 |
Why?
|
| HSP90 Heat-Shock Proteins | 19 | 2023 | 434 | 4.880 |
Why?
|
| Heat-Shock Response | 19 | 2023 | 165 | 4.340 |
Why?
|
| Scavenger Receptors, Class F | 6 | 2020 | 16 | 2.960 |
Why?
|
| Receptors, Scavenger | 7 | 2023 | 121 | 2.760 |
Why?
|
| DNA-Binding Proteins | 47 | 2023 | 9647 | 2.750 |
Why?
|
| Transcription, Genetic | 37 | 2021 | 7721 | 2.230 |
Why?
|
| Transcription Factors | 50 | 2023 | 12207 | 1.850 |
Why?
|
| DNA Topoisomerases, Type II | 3 | 2021 | 121 | 1.810 |
Why?
|
| Cancer Vaccines | 13 | 2023 | 1023 | 1.730 |
Why?
|
| HSP72 Heat-Shock Proteins | 9 | 2015 | 39 | 1.720 |
Why?
|
| Neoplasms | 36 | 2023 | 21696 | 1.560 |
Why?
|
| NF-E2-Related Factor 2 | 3 | 2023 | 379 | 1.550 |
Why?
|
| Stress, Physiological | 6 | 2021 | 1403 | 1.410 |
Why?
|
| Hot Temperature | 32 | 2023 | 1356 | 1.370 |
Why?
|
| Hyperthermia, Induced | 11 | 2011 | 403 | 1.350 |
Why?
|
| RNA Polymerase II | 5 | 2015 | 550 | 1.330 |
Why?
|
| Chaperonins | 4 | 2020 | 62 | 1.310 |
Why?
|
| Cross-Priming | 4 | 2015 | 82 | 1.310 |
Why?
|
| Promoter Regions, Genetic | 28 | 2020 | 5867 | 1.270 |
Why?
|
| Signal Transduction | 33 | 2021 | 23404 | 1.240 |
Why?
|
| Gene Expression Regulation, Neoplastic | 13 | 2022 | 8432 | 1.090 |
Why?
|
| Cell Transformation, Neoplastic | 9 | 2020 | 2943 | 1.070 |
Why?
|
| Exosomes | 3 | 2022 | 417 | 1.060 |
Why?
|
| Monocytes | 10 | 2015 | 2596 | 1.020 |
Why?
|
| Epithelial-Mesenchymal Transition | 5 | 2022 | 713 | 0.980 |
Why?
|
| Repressor Proteins | 8 | 2018 | 3024 | 0.980 |
Why?
|
| Lectins, C-Type | 3 | 2023 | 589 | 0.960 |
Why?
|
| HeLa Cells | 20 | 2021 | 3130 | 0.930 |
Why?
|
| Prostatic Neoplasms | 17 | 2023 | 11126 | 0.890 |
Why?
|
| Cell Line, Tumor | 31 | 2023 | 16690 | 0.860 |
Why?
|
| Dendritic Cells | 12 | 2023 | 2725 | 0.860 |
Why?
|
| Mammary Neoplasms, Experimental | 7 | 2015 | 520 | 0.850 |
Why?
|
| Animals | 131 | 2023 | 168768 | 0.820 |
Why?
|
| Endocytosis | 3 | 2020 | 985 | 0.810 |
Why?
|
| Medicine | 2 | 2022 | 946 | 0.810 |
Why?
|
| Phosphorylation | 27 | 2021 | 8436 | 0.800 |
Why?
|
| Antigen Presentation | 6 | 2015 | 1284 | 0.800 |
Why?
|
| Receptors, Cell Surface | 7 | 2015 | 2865 | 0.790 |
Why?
|
| MicroRNAs | 4 | 2023 | 3751 | 0.740 |
Why?
|
| Scavenger Receptors, Class E | 1 | 2020 | 8 | 0.740 |
Why?
|
| Biology | 2 | 2022 | 295 | 0.730 |
Why?
|
| Chromatography, Ion Exchange | 2 | 2018 | 306 | 0.730 |
Why?
|
| Gene Expression Regulation | 23 | 2021 | 12073 | 0.720 |
Why?
|
| Toll-Like Receptor 4 | 3 | 2015 | 565 | 0.710 |
Why?
|
| Cell Nucleus | 11 | 2016 | 2969 | 0.700 |
Why?
|
| Mammary Neoplasms, Animal | 3 | 2018 | 137 | 0.690 |
Why?
|
| Chromatin Immunoprecipitation | 3 | 2018 | 894 | 0.670 |
Why?
|
| Cyclic AMP-Dependent Protein Kinases | 2 | 2011 | 491 | 0.660 |
Why?
|
| Immediate-Early Proteins | 1 | 2021 | 453 | 0.650 |
Why?
|
| Neoplastic Stem Cells | 6 | 2018 | 1376 | 0.650 |
Why?
|
| DNA-Activated Protein Kinase | 2 | 2015 | 117 | 0.650 |
Why?
|
| Protein Binding | 26 | 2019 | 9384 | 0.640 |
Why?
|
| RNA, Double-Stranded | 2 | 2014 | 290 | 0.640 |
Why?
|
| Cell Fusion | 7 | 2018 | 297 | 0.640 |
Why?
|
| Immune System | 4 | 2008 | 806 | 0.620 |
Why?
|
| High-Throughput Nucleotide Sequencing | 2 | 2023 | 3595 | 0.620 |
Why?
|
| Phagocytes | 1 | 2020 | 297 | 0.620 |
Why?
|
| Lipopolysaccharides | 10 | 2022 | 2216 | 0.620 |
Why?
|
| Serine | 5 | 2010 | 826 | 0.620 |
Why?
|
| Antigens, Ly | 2 | 2018 | 291 | 0.610 |
Why?
|
| Workflow | 2 | 2023 | 847 | 0.590 |
Why?
|
| Cell Cycle Proteins | 4 | 2020 | 3464 | 0.580 |
Why?
|
| Neurodegenerative Diseases | 3 | 2022 | 1061 | 0.580 |
Why?
|
| Microglia | 2 | 2022 | 1267 | 0.580 |
Why?
|
| Immunotherapy | 10 | 2018 | 4446 | 0.570 |
Why?
|
| CHO Cells | 11 | 2018 | 1409 | 0.560 |
Why?
|
| Interleukin-1 | 6 | 2006 | 1263 | 0.560 |
Why?
|
| Antigens, Neoplasm | 9 | 2023 | 1988 | 0.560 |
Why?
|
| Genes, fos | 3 | 2002 | 183 | 0.550 |
Why?
|
| Cricetinae | 24 | 2011 | 2475 | 0.550 |
Why?
|
| DNA Damage | 7 | 2018 | 2432 | 0.550 |
Why?
|
| Transfection | 18 | 2023 | 5895 | 0.540 |
Why?
|
| HSP27 Heat-Shock Proteins | 1 | 2016 | 69 | 0.540 |
Why?
|
| DNA Breaks | 1 | 2015 | 49 | 0.540 |
Why?
|
| Humans | 147 | 2023 | 744366 | 0.540 |
Why?
|
| Mice | 68 | 2022 | 81201 | 0.530 |
Why?
|
| NF-kappa B | 12 | 2022 | 2499 | 0.530 |
Why?
|
| Health | 1 | 2019 | 394 | 0.530 |
Why?
|
| Ubiquitin-Protein Ligases | 3 | 2021 | 1862 | 0.530 |
Why?
|
| Lectins | 3 | 2015 | 513 | 0.510 |
Why?
|
| Neoplasm Proteins | 4 | 2018 | 3707 | 0.500 |
Why?
|
| BRCA1 Protein | 1 | 2021 | 1149 | 0.500 |
Why?
|
| DNA Breaks, Double-Stranded | 2 | 2016 | 594 | 0.490 |
Why?
|
| Toll-Like Receptor 3 | 1 | 2014 | 91 | 0.490 |
Why?
|
| Cell Line | 35 | 2014 | 16000 | 0.480 |
Why?
|
| Antigens, Differentiation, Myelomonocytic | 1 | 2015 | 294 | 0.480 |
Why?
|
| Membrane Microdomains | 1 | 2015 | 203 | 0.470 |
Why?
|
| HEK293 Cells | 9 | 2021 | 4208 | 0.470 |
Why?
|
| Sequence Analysis, RNA | 2 | 2023 | 2012 | 0.470 |
Why?
|
| Molecular Biology | 1 | 2018 | 596 | 0.470 |
Why?
|
| Autophagy | 4 | 2023 | 1297 | 0.460 |
Why?
|
| Antigen-Presenting Cells | 5 | 2013 | 973 | 0.460 |
Why?
|
| Mitogen-Activated Protein Kinases | 6 | 2015 | 1284 | 0.460 |
Why?
|
| Oxidative Stress | 6 | 2023 | 3084 | 0.460 |
Why?
|
| Cell Survival | 21 | 2021 | 5882 | 0.460 |
Why?
|
| Longevity | 2 | 2013 | 1071 | 0.460 |
Why?
|
| Cytoplasm | 7 | 2015 | 1536 | 0.450 |
Why?
|
| Protein Transport | 6 | 2014 | 1988 | 0.450 |
Why?
|
| Chemical Fractionation | 1 | 2013 | 65 | 0.440 |
Why?
|
| Disease | 1 | 2019 | 680 | 0.440 |
Why?
|
| Radiation-Sensitizing Agents | 4 | 2010 | 358 | 0.440 |
Why?
|
| Tumor Suppressor Proteins | 2 | 2021 | 2850 | 0.440 |
Why?
|
| Kruppel-Like Transcription Factors | 1 | 2015 | 504 | 0.430 |
Why?
|
| Apoptosis | 11 | 2021 | 9724 | 0.430 |
Why?
|
| Calcium-Calmodulin-Dependent Protein Kinases | 4 | 2000 | 494 | 0.420 |
Why?
|
| Oncogenes | 4 | 2015 | 1265 | 0.420 |
Why?
|
| Fever | 3 | 2011 | 1616 | 0.420 |
Why?
|
| DNA | 11 | 2018 | 7294 | 0.420 |
Why?
|
| Ribosomal Protein S6 Kinases | 3 | 2004 | 205 | 0.420 |
Why?
|
| Nanotechnology | 1 | 2018 | 710 | 0.410 |
Why?
|
| Protein Biosynthesis | 5 | 2012 | 2126 | 0.410 |
Why?
|
| Organoids | 1 | 2018 | 701 | 0.410 |
Why?
|
| Tumor Cells, Cultured | 18 | 2021 | 6313 | 0.390 |
Why?
|
| Osteocytes | 1 | 2013 | 197 | 0.390 |
Why?
|
| CCAAT-Enhancer-Binding Protein-beta | 2 | 2002 | 103 | 0.390 |
Why?
|
| Endosomes | 4 | 2010 | 519 | 0.390 |
Why?
|
| Histocompatibility Antigens Class II | 2 | 2018 | 1475 | 0.380 |
Why?
|
| Cricetulus | 16 | 2018 | 818 | 0.380 |
Why?
|
| Peptides | 8 | 2023 | 4410 | 0.380 |
Why?
|
| Neoplasm Metastasis | 4 | 2018 | 4851 | 0.380 |
Why?
|
| Myeloid Cells | 1 | 2015 | 810 | 0.370 |
Why?
|
| T-Lymphocytes, Cytotoxic | 5 | 2023 | 1821 | 0.370 |
Why?
|
| Neurons | 5 | 2021 | 9340 | 0.370 |
Why?
|
| Cell Differentiation | 6 | 2021 | 11486 | 0.360 |
Why?
|
| Immunotherapy, Active | 1 | 2009 | 60 | 0.350 |
Why?
|
| 14-3-3 Proteins | 3 | 2004 | 214 | 0.340 |
Why?
|
| Extracellular Fluid | 2 | 2007 | 167 | 0.340 |
Why?
|
| Toll-Like Receptor 2 | 2 | 2009 | 354 | 0.340 |
Why?
|
| 3T3 Cells | 12 | 2002 | 1101 | 0.330 |
Why?
|
| beta Catenin | 1 | 2014 | 1059 | 0.330 |
Why?
|
| TOR Serine-Threonine Kinases | 3 | 2014 | 2110 | 0.330 |
Why?
|
| Interleukin-6 | 6 | 2011 | 3203 | 0.330 |
Why?
|
| Mouth Neoplasms | 3 | 2018 | 601 | 0.330 |
Why?
|
| Protein Processing, Post-Translational | 5 | 2015 | 1988 | 0.330 |
Why?
|
| Antigens, CD | 2 | 2018 | 4026 | 0.330 |
Why?
|
| Anti-Inflammatory Agents, Non-Steroidal | 6 | 2002 | 2282 | 0.330 |
Why?
|
| Awards and Prizes | 1 | 2013 | 375 | 0.330 |
Why?
|
| Neuregulin-1 | 2 | 2007 | 142 | 0.320 |
Why?
|
| Lysosomes | 3 | 2011 | 893 | 0.320 |
Why?
|
| Mice, Inbred C57BL | 16 | 2018 | 21833 | 0.300 |
Why?
|
| Quercetin | 3 | 2004 | 93 | 0.300 |
Why?
|
| Osteoblasts | 1 | 2013 | 1166 | 0.300 |
Why?
|
| Leukemia | 1 | 2015 | 1510 | 0.290 |
Why?
|
| Aging | 5 | 2014 | 8664 | 0.290 |
Why?
|
| Membrane Proteins | 6 | 2018 | 7882 | 0.290 |
Why?
|
| Breast Neoplasms | 7 | 2021 | 20824 | 0.280 |
Why?
|
| Sarcopenia | 1 | 2011 | 368 | 0.280 |
Why?
|
| Genes, fms | 2 | 2002 | 6 | 0.280 |
Why?
|
| Histone Deacetylases | 2 | 2009 | 728 | 0.280 |
Why?
|
| eIF-2 Kinase | 2 | 2008 | 150 | 0.280 |
Why?
|
| NIH 3T3 Cells | 3 | 2018 | 677 | 0.270 |
Why?
|
| Microscopy, Confocal | 4 | 2015 | 1970 | 0.270 |
Why?
|
| HSP40 Heat-Shock Proteins | 2 | 2020 | 80 | 0.270 |
Why?
|
| Histones | 2 | 2015 | 2598 | 0.270 |
Why?
|
| Tumor Necrosis Factor-alpha | 8 | 2011 | 4424 | 0.270 |
Why?
|
| Cell Membrane | 6 | 2014 | 3749 | 0.270 |
Why?
|
| MAP Kinase Kinase 2 | 1 | 2005 | 94 | 0.270 |
Why?
|
| Disease Progression | 3 | 2019 | 13286 | 0.260 |
Why?
|
| Plasmids | 7 | 2007 | 2308 | 0.260 |
Why?
|
| Models, Biological | 8 | 2019 | 9584 | 0.260 |
Why?
|
| Chaperonin 60 | 3 | 2012 | 103 | 0.260 |
Why?
|
| Neovascularization, Pathologic | 1 | 2016 | 2638 | 0.260 |
Why?
|
| Macrophages | 6 | 2015 | 5660 | 0.260 |
Why?
|
| RNA, Messenger | 11 | 2018 | 13035 | 0.260 |
Why?
|
| Nuclear Proteins | 2 | 2015 | 5856 | 0.260 |
Why?
|
| Mitogen-Activated Protein Kinase 3 | 2 | 2004 | 480 | 0.250 |
Why?
|
| Ibuprofen | 3 | 2001 | 236 | 0.250 |
Why?
|
| Cell Division | 4 | 2007 | 4569 | 0.250 |
Why?
|
| Genes, Reporter | 7 | 2007 | 1547 | 0.250 |
Why?
|
| Cytokines | 6 | 2015 | 7323 | 0.250 |
Why?
|
| Molecular Sequence Data | 13 | 2012 | 18111 | 0.240 |
Why?
|
| Transcriptional Activation | 5 | 2004 | 1783 | 0.240 |
Why?
|
| Mitogen-Activated Protein Kinase Kinases | 3 | 2022 | 647 | 0.240 |
Why?
|
| Calcium | 9 | 2000 | 5755 | 0.230 |
Why?
|
| Isoenzymes | 2 | 2018 | 1728 | 0.230 |
Why?
|
| Binding Sites | 7 | 2018 | 6111 | 0.220 |
Why?
|
| Untranslated Regions | 1 | 2022 | 31 | 0.220 |
Why?
|
| Phagocytosis | 2 | 2021 | 1539 | 0.220 |
Why?
|
| Electrophoretic Mobility Shift Assay | 3 | 2018 | 300 | 0.220 |
Why?
|
| Antigens | 1 | 2008 | 1466 | 0.210 |
Why?
|
| Type C Phospholipases | 2 | 1993 | 292 | 0.210 |
Why?
|
| Immunity, Cellular | 2 | 2013 | 1607 | 0.210 |
Why?
|
| Tetrazolium Salts | 1 | 2002 | 96 | 0.210 |
Why?
|
| Sphingosine | 1 | 2004 | 307 | 0.210 |
Why?
|
| Cell Movement | 3 | 2022 | 5218 | 0.210 |
Why?
|
| Toll-Like Receptors | 4 | 2015 | 593 | 0.210 |
Why?
|
| Genes, Dominant | 2 | 2008 | 880 | 0.210 |
Why?
|
| Estrogen Receptor alpha | 1 | 2006 | 577 | 0.210 |
Why?
|
| Threonine | 1 | 2003 | 279 | 0.210 |
Why?
|
| Inflammation | 11 | 2014 | 10637 | 0.210 |
Why?
|
| Tyrosine 3-Monooxygenase | 1 | 2003 | 375 | 0.210 |
Why?
|
| Mesenchymal Stem Cells | 1 | 2013 | 1632 | 0.210 |
Why?
|
| Gene Expression | 9 | 2021 | 7798 | 0.210 |
Why?
|
| Base Sequence | 10 | 2020 | 12797 | 0.210 |
Why?
|
| Cell Proliferation | 10 | 2021 | 10483 | 0.210 |
Why?
|
| Sulindac | 1 | 2001 | 29 | 0.210 |
Why?
|
| Adenosine Triphosphate | 6 | 2011 | 2027 | 0.200 |
Why?
|
| Receptors, Progesterone | 1 | 2006 | 1098 | 0.200 |
Why?
|
| Cyclooxygenase Inhibitors | 2 | 2001 | 371 | 0.200 |
Why?
|
| Phosphoserine | 3 | 2012 | 206 | 0.200 |
Why?
|
| Luciferases | 5 | 2004 | 733 | 0.200 |
Why?
|
| Temperature | 6 | 2004 | 2204 | 0.200 |
Why?
|
| Endothelial Cells | 3 | 2009 | 3486 | 0.200 |
Why?
|
| Early Growth Response Protein 1 | 1 | 2021 | 138 | 0.200 |
Why?
|
| Peptide Fragments | 3 | 2013 | 5096 | 0.200 |
Why?
|
| Cloning, Molecular | 5 | 2018 | 4320 | 0.200 |
Why?
|
| Proteostasis Deficiencies | 1 | 2021 | 38 | 0.200 |
Why?
|
| Transcription Initiation Site | 1 | 2021 | 196 | 0.190 |
Why?
|
| Amino Acid Sequence | 8 | 2012 | 13814 | 0.190 |
Why?
|
| Protein Structure, Tertiary | 4 | 2015 | 3848 | 0.190 |
Why?
|
| Immunoblotting | 3 | 2010 | 1683 | 0.190 |
Why?
|
| Culture Media, Conditioned | 1 | 2022 | 537 | 0.190 |
Why?
|
| I-kappa B Proteins | 2 | 2006 | 225 | 0.190 |
Why?
|
| Aneuploidy | 1 | 2004 | 530 | 0.190 |
Why?
|
| Chromatin | 3 | 2022 | 2933 | 0.190 |
Why?
|
| Estrogens | 1 | 2007 | 1566 | 0.180 |
Why?
|
| Tumor Suppressor Protein p53 | 4 | 2016 | 2949 | 0.180 |
Why?
|
| Antigens, Nuclear | 1 | 2001 | 192 | 0.180 |
Why?
|
| Blotting, Northern | 6 | 2002 | 1581 | 0.180 |
Why?
|
| DNA Helicases | 2 | 2007 | 861 | 0.180 |
Why?
|
| Lymphatic Metastasis | 2 | 2018 | 2924 | 0.180 |
Why?
|
| Antineoplastic Agents | 7 | 2020 | 13693 | 0.180 |
Why?
|
| Gene Expression Profiling | 4 | 2023 | 9445 | 0.180 |
Why?
|
| Cell Hypoxia | 3 | 2018 | 675 | 0.180 |
Why?
|
| Salicylic Acid | 1 | 1999 | 56 | 0.180 |
Why?
|
| G1 Phase | 2 | 1999 | 415 | 0.180 |
Why?
|
| Enzyme Inhibitors | 5 | 2018 | 3799 | 0.180 |
Why?
|
| Cell Death | 4 | 2012 | 1707 | 0.180 |
Why?
|
| Mi-2 Nucleosome Remodeling and Deacetylase Complex | 2 | 2012 | 112 | 0.180 |
Why?
|
| Receptors, Cytoplasmic and Nuclear | 2 | 2007 | 871 | 0.180 |
Why?
|
| Adenocarcinoma | 3 | 2023 | 6364 | 0.180 |
Why?
|
| Mammary Glands, Human | 1 | 2021 | 199 | 0.170 |
Why?
|
| Receptor, erbB-2 | 2 | 2006 | 2417 | 0.170 |
Why?
|
| Radiation Tolerance | 2 | 2013 | 486 | 0.170 |
Why?
|
| Mice, Knockout | 6 | 2018 | 14561 | 0.170 |
Why?
|
| Recombinant Proteins | 9 | 2009 | 6621 | 0.170 |
Why?
|
| Cells | 2 | 1993 | 168 | 0.170 |
Why?
|
| L-Lactate Dehydrogenase | 1 | 2020 | 424 | 0.170 |
Why?
|
| Phosphoprotein Phosphatases | 1 | 2000 | 338 | 0.170 |
Why?
|
| Cell Shape | 1 | 2020 | 375 | 0.160 |
Why?
|
| Protein Folding | 2 | 2015 | 840 | 0.160 |
Why?
|
| Epidermal Growth Factor | 2 | 2018 | 709 | 0.160 |
Why?
|
| Immunoprecipitation | 4 | 2010 | 906 | 0.160 |
Why?
|
| Mutagenesis, Site-Directed | 4 | 2004 | 1723 | 0.160 |
Why?
|
| Retinal Dehydrogenase | 1 | 2018 | 74 | 0.160 |
Why?
|
| Comet Assay | 2 | 2015 | 71 | 0.160 |
Why?
|
| Cytosol | 2 | 2013 | 901 | 0.160 |
Why?
|
| Integrin alpha Chains | 1 | 2018 | 97 | 0.160 |
Why?
|
| Tissue Distribution | 2 | 2022 | 2327 | 0.160 |
Why?
|
| Epithelial Cells | 6 | 2020 | 3690 | 0.160 |
Why?
|
| Drug Resistance, Neoplasm | 4 | 2020 | 5172 | 0.160 |
Why?
|
| Blotting, Western | 6 | 2007 | 5181 | 0.160 |
Why?
|
| Carcinoma | 2 | 2012 | 2375 | 0.160 |
Why?
|
| Spodoptera | 1 | 2018 | 153 | 0.150 |
Why?
|
| Mutation | 10 | 2021 | 29786 | 0.150 |
Why?
|
| Genes, ras | 1 | 2000 | 690 | 0.150 |
Why?
|
| Fluorescent Antibody Technique | 2 | 2015 | 2505 | 0.150 |
Why?
|
| Cell Membrane Permeability | 3 | 2007 | 590 | 0.150 |
Why?
|
| Electrophoresis, Polyacrylamide Gel | 5 | 2004 | 1801 | 0.150 |
Why?
|
| Fibroblasts | 9 | 2009 | 4162 | 0.150 |
Why?
|
| Neoplasm Transplantation | 5 | 2012 | 2086 | 0.150 |
Why?
|
| Apoptosis Regulatory Proteins | 2 | 2014 | 1157 | 0.150 |
Why?
|
| Mammals | 1 | 2023 | 1143 | 0.150 |
Why?
|
| Cyclic AMP Response Element-Binding Protein | 1 | 1999 | 514 | 0.150 |
Why?
|
| Vaccines, Synthetic | 3 | 2023 | 634 | 0.150 |
Why?
|
| Extracellular Space | 2 | 2010 | 595 | 0.140 |
Why?
|
| Inflammation Mediators | 2 | 2015 | 1888 | 0.140 |
Why?
|
| Ubiquitination | 1 | 2021 | 1012 | 0.140 |
Why?
|
| Chromatography, High Pressure Liquid | 1 | 2000 | 1572 | 0.140 |
Why?
|
| Lymphocyte Activation | 8 | 2013 | 5524 | 0.140 |
Why?
|
| Proteins | 1 | 2011 | 6100 | 0.140 |
Why?
|
| Phosphatidylinositols | 2 | 1988 | 291 | 0.140 |
Why?
|
| Proteome | 3 | 2020 | 1798 | 0.140 |
Why?
|
| Amino Acid Substitution | 3 | 2010 | 1793 | 0.140 |
Why?
|
| Cells, Cultured | 13 | 2009 | 19233 | 0.140 |
Why?
|
| Cyclin-Dependent Kinase 2 | 1 | 2016 | 191 | 0.140 |
Why?
|
| Deoxyglucose | 3 | 2014 | 337 | 0.140 |
Why?
|
| Genes, p53 | 2 | 2004 | 755 | 0.140 |
Why?
|
| Positive Transcriptional Elongation Factor B | 1 | 2015 | 42 | 0.140 |
Why?
|
| Matrix Metalloproteinase 3 | 1 | 2016 | 134 | 0.140 |
Why?
|
| Mice, Nude | 5 | 2014 | 3689 | 0.140 |
Why?
|
| Protein Kinase C | 2 | 1998 | 1227 | 0.130 |
Why?
|
| Tetradecanoylphorbol Acetate | 2 | 1994 | 821 | 0.130 |
Why?
|
| Terpenes | 2 | 1992 | 98 | 0.130 |
Why?
|
| Reactive Oxygen Species | 2 | 1994 | 2076 | 0.130 |
Why?
|
| Response Elements | 2 | 2010 | 312 | 0.130 |
Why?
|
| Drug Screening Assays, Antitumor | 2 | 2016 | 730 | 0.130 |
Why?
|
| Receptor, Insulin | 3 | 1983 | 847 | 0.130 |
Why?
|
| Point Mutation | 1 | 2000 | 1624 | 0.130 |
Why?
|
| Phospholipases A | 2 | 1993 | 216 | 0.130 |
Why?
|
| Enzyme Activation | 6 | 2004 | 3702 | 0.130 |
Why?
|
| Leukotriene B4 | 2 | 2001 | 294 | 0.130 |
Why?
|
| Sumoylation | 1 | 2015 | 83 | 0.130 |
Why?
|
| Kinetics | 9 | 2004 | 6476 | 0.130 |
Why?
|
| Colony-Forming Units Assay | 2 | 2007 | 356 | 0.130 |
Why?
|
| G Protein-Coupled Inwardly-Rectifying Potassium Channels | 1 | 2014 | 64 | 0.130 |
Why?
|
| Proto-Oncogene Proteins c-fos | 1 | 1997 | 575 | 0.130 |
Why?
|
| Chromatography, Affinity | 2 | 2013 | 549 | 0.120 |
Why?
|
| Poly I-C | 1 | 2014 | 115 | 0.120 |
Why?
|
| Combined Modality Therapy | 7 | 2013 | 8642 | 0.120 |
Why?
|
| Mice, SCID | 1 | 2020 | 2716 | 0.120 |
Why?
|
| Glycogen Synthase Kinase 3 | 3 | 2005 | 430 | 0.120 |
Why?
|
| Morbidity | 1 | 2020 | 1768 | 0.120 |
Why?
|
| Green Fluorescent Proteins | 3 | 2012 | 2088 | 0.120 |
Why?
|
| Exercise | 2 | 2011 | 5615 | 0.120 |
Why?
|
| Protein Denaturation | 3 | 2011 | 237 | 0.120 |
Why?
|
| Neoplasm Invasiveness | 1 | 2022 | 3616 | 0.120 |
Why?
|
| Transcriptional Elongation Factors | 1 | 2015 | 166 | 0.120 |
Why?
|
| DNA Repair Enzymes | 1 | 2016 | 349 | 0.120 |
Why?
|
| Protein Stability | 1 | 2016 | 556 | 0.120 |
Why?
|
| DNA Primers | 3 | 2011 | 2891 | 0.120 |
Why?
|
| Shock | 2 | 1993 | 318 | 0.120 |
Why?
|
| Chondrosarcoma | 1 | 2016 | 309 | 0.120 |
Why?
|
| Ovary | 8 | 1987 | 981 | 0.120 |
Why?
|
| cdc42 GTP-Binding Protein | 1 | 2014 | 193 | 0.120 |
Why?
|
| Antioxidants | 1 | 2021 | 1659 | 0.110 |
Why?
|
| Protein Kinases | 1 | 2000 | 1640 | 0.110 |
Why?
|
| Mice, Inbred BALB C | 8 | 2018 | 6386 | 0.110 |
Why?
|
| Intracellular Space | 1 | 2014 | 212 | 0.110 |
Why?
|
| Prenatal Nutritional Physiological Phenomena | 1 | 2014 | 159 | 0.110 |
Why?
|
| Dental Pulp | 1 | 2013 | 82 | 0.110 |
Why?
|
| Spectrometry, Mass, Matrix-Assisted Laser Desorption-Ionization | 2 | 2005 | 504 | 0.110 |
Why?
|
| Nitric Oxide | 1 | 2022 | 2132 | 0.110 |
Why?
|
| Substrate Specificity | 2 | 2012 | 1802 | 0.110 |
Why?
|
| RNA Splicing | 1 | 2018 | 908 | 0.110 |
Why?
|
| Down-Regulation | 3 | 2015 | 3001 | 0.110 |
Why?
|
| Aluminum Compounds | 1 | 1992 | 51 | 0.110 |
Why?
|
| Melanoma, Experimental | 3 | 2014 | 561 | 0.110 |
Why?
|
| DNA Mutational Analysis | 2 | 2001 | 4185 | 0.110 |
Why?
|
| Fluorine | 1 | 1992 | 83 | 0.110 |
Why?
|
| RNA Polymerase III | 1 | 1992 | 51 | 0.110 |
Why?
|
| Glutathione Transferase | 3 | 2004 | 595 | 0.110 |
Why?
|
| Guanosine Triphosphate | 1 | 1993 | 321 | 0.110 |
Why?
|
| Drosophila Proteins | 1 | 2002 | 1703 | 0.110 |
Why?
|
| Cyclopentanes | 1 | 1992 | 91 | 0.110 |
Why?
|
| Carcinoma, Squamous Cell | 2 | 2018 | 4034 | 0.110 |
Why?
|
| Phenotype | 5 | 2013 | 16367 | 0.100 |
Why?
|
| Protein Precursors | 1 | 1996 | 1154 | 0.100 |
Why?
|
| Ligands | 2 | 2018 | 3282 | 0.100 |
Why?
|
| Fluorides | 1 | 1992 | 127 | 0.100 |
Why?
|
| T-Lymphocytes | 7 | 2015 | 10183 | 0.100 |
Why?
|
| Aluminum | 1 | 1992 | 152 | 0.100 |
Why?
|
| Sodium Salicylate | 2 | 2002 | 19 | 0.100 |
Why?
|
| Rats | 12 | 2014 | 24252 | 0.100 |
Why?
|
| Calcimycin | 4 | 2000 | 222 | 0.100 |
Why?
|
| Thapsigargin | 3 | 2000 | 104 | 0.100 |
Why?
|
| Molecular Targeted Therapy | 2 | 2020 | 2725 | 0.100 |
Why?
|
| PC12 Cells | 1 | 2011 | 331 | 0.100 |
Why?
|
| Phosphotransferases | 1 | 2012 | 308 | 0.100 |
Why?
|
| MAP Kinase Kinase Kinase 1 | 1 | 2011 | 58 | 0.100 |
Why?
|
| Male | 22 | 2023 | 350115 | 0.100 |
Why?
|
| Protein Unfolding | 1 | 2011 | 54 | 0.100 |
Why?
|
| Protein Conformation | 3 | 2015 | 4010 | 0.090 |
Why?
|
| Proto-Oncogene Proteins c-met | 1 | 2015 | 578 | 0.090 |
Why?
|
| Membrane Glycoproteins | 1 | 2002 | 3771 | 0.090 |
Why?
|
| Cycloheximide | 3 | 1999 | 347 | 0.090 |
Why?
|
| Sugar Phosphates | 2 | 1987 | 43 | 0.090 |
Why?
|
| Sarcoma, Yoshida | 2 | 1980 | 11 | 0.090 |
Why?
|
| Glycosylphosphatidylinositols | 1 | 2010 | 94 | 0.090 |
Why?
|
| CD8-Positive T-Lymphocytes | 5 | 2013 | 4479 | 0.090 |
Why?
|
| DEAE-Dextran | 2 | 1986 | 10 | 0.090 |
Why?
|
| Multiprotein Complexes | 2 | 2006 | 1120 | 0.090 |
Why?
|
| Imidazoles | 1 | 2016 | 1206 | 0.090 |
Why?
|
| Stem Cells | 2 | 2013 | 3567 | 0.090 |
Why?
|
| Proto-Oncogene Proteins p21(ras) | 1 | 1997 | 1692 | 0.090 |
Why?
|
| Inositol Phosphates | 2 | 1987 | 180 | 0.090 |
Why?
|
| Reverse Transcriptase Polymerase Chain Reaction | 3 | 2003 | 4751 | 0.090 |
Why?
|
| Tumor Microenvironment | 1 | 2022 | 3590 | 0.090 |
Why?
|
| Calmodulin | 1 | 1990 | 209 | 0.090 |
Why?
|
| Female | 30 | 2021 | 380193 | 0.090 |
Why?
|
| Enzyme-Linked Immunosorbent Assay | 2 | 2006 | 3873 | 0.090 |
Why?
|
| Cytotoxicity Tests, Immunologic | 1 | 2009 | 329 | 0.090 |
Why?
|
| Amyloid beta-Peptides | 1 | 2022 | 3587 | 0.090 |
Why?
|
| Arachidonic Acids | 1 | 1989 | 299 | 0.080 |
Why?
|
| Immunity, Innate | 1 | 2021 | 2962 | 0.080 |
Why?
|
| GTP-Binding Proteins | 1 | 1993 | 970 | 0.080 |
Why?
|
| Prostaglandins | 1 | 1989 | 405 | 0.080 |
Why?
|
| Oligonucleotides | 2 | 2010 | 572 | 0.080 |
Why?
|
| Catalytic Domain | 1 | 2010 | 698 | 0.080 |
Why?
|
| MAP Kinase Signaling System | 2 | 2006 | 1525 | 0.080 |
Why?
|
| beta-Galactosidase | 2 | 2000 | 574 | 0.080 |
Why?
|
| Glycogen Synthase Kinases | 2 | 1998 | 40 | 0.080 |
Why?
|
| In Situ Nick-End Labeling | 2 | 2010 | 644 | 0.080 |
Why?
|
| Malnutrition | 1 | 2014 | 625 | 0.080 |
Why?
|
| Indoles | 1 | 2016 | 1839 | 0.080 |
Why?
|
| Cell Cycle | 4 | 2021 | 2967 | 0.080 |
Why?
|
| Tumor Stem Cell Assay | 2 | 2005 | 118 | 0.080 |
Why?
|
| RNA, Catalytic | 1 | 2007 | 50 | 0.080 |
Why?
|
| RNA | 4 | 2023 | 2749 | 0.080 |
Why?
|
| Drug Discovery | 2 | 2016 | 1058 | 0.080 |
Why?
|
| Interleukin-1beta | 3 | 2011 | 972 | 0.080 |
Why?
|
| Aspirin | 1 | 1999 | 3283 | 0.080 |
Why?
|
| Histone Deacetylase 2 | 1 | 2007 | 74 | 0.080 |
Why?
|
| Dextrans | 2 | 1986 | 595 | 0.080 |
Why?
|
| Adenosine Diphosphate | 2 | 2005 | 425 | 0.080 |
Why?
|
| Receptors, Concanavalin A | 1 | 1986 | 11 | 0.070 |
Why?
|
| Lysosomal-Associated Membrane Protein 1 | 1 | 2006 | 26 | 0.070 |
Why?
|
| Pheochromocytoma | 1 | 1989 | 337 | 0.070 |
Why?
|
| Receptor Aggregation | 1 | 1986 | 80 | 0.070 |
Why?
|
| Trypan Blue | 1 | 2006 | 21 | 0.070 |
Why?
|
| Mutagenesis | 2 | 2004 | 1264 | 0.070 |
Why?
|
| Histone Deacetylase 1 | 1 | 2007 | 137 | 0.070 |
Why?
|
| Leupeptins | 1 | 2006 | 122 | 0.070 |
Why?
|
| Karyopherins | 2 | 2007 | 137 | 0.070 |
Why?
|
| Telomere | 2 | 2010 | 910 | 0.070 |
Why?
|
| Energy Metabolism | 4 | 1988 | 2897 | 0.070 |
Why?
|
| 3' Untranslated Regions | 2 | 2013 | 513 | 0.070 |
Why?
|
| Structure-Activity Relationship | 3 | 2006 | 3130 | 0.070 |
Why?
|
| Lymphocyte Subsets | 1 | 2008 | 315 | 0.070 |
Why?
|
| Emetine | 1 | 2006 | 15 | 0.070 |
Why?
|
| Alleles | 1 | 2018 | 6933 | 0.070 |
Why?
|
| DNA Fragmentation | 2 | 2004 | 242 | 0.070 |
Why?
|
| DNA Repair | 2 | 2015 | 2046 | 0.070 |
Why?
|
| Homeodomain Proteins | 2 | 2013 | 2418 | 0.070 |
Why?
|
| Oncogene Proteins v-erbB | 1 | 2005 | 17 | 0.070 |
Why?
|
| Biological Evolution | 1 | 1992 | 1077 | 0.070 |
Why?
|
| Peptide Hydrolases | 1 | 2009 | 634 | 0.070 |
Why?
|
| HMGB1 Protein | 1 | 2007 | 134 | 0.070 |
Why?
|
| Precipitin Tests | 3 | 2002 | 829 | 0.070 |
Why?
|
| RNA, Neoplasm | 2 | 2007 | 769 | 0.070 |
Why?
|
| Cytotoxicity, Immunologic | 1 | 2009 | 1369 | 0.070 |
Why?
|
| Hydrogen Peroxide | 4 | 2009 | 730 | 0.070 |
Why?
|
| Gene Silencing | 1 | 2012 | 1539 | 0.070 |
Why?
|
| History, 21st Century | 1 | 2011 | 1534 | 0.070 |
Why?
|
| Dose-Response Relationship, Drug | 5 | 2005 | 10943 | 0.060 |
Why?
|
| DNA, Antisense | 1 | 2004 | 46 | 0.060 |
Why?
|
| Chromatography, Gel | 1 | 2005 | 668 | 0.060 |
Why?
|
| Recombinant Fusion Proteins | 4 | 2008 | 3773 | 0.060 |
Why?
|
| Ribosomal Protein S6 Kinases, 90-kDa | 1 | 2004 | 56 | 0.060 |
Why?
|
| Demecolcine | 1 | 2004 | 18 | 0.060 |
Why?
|
| Vascular Endothelial Growth Factor A | 1 | 2016 | 3511 | 0.060 |
Why?
|
| Major Histocompatibility Complex | 1 | 2008 | 936 | 0.060 |
Why?
|
| Cyclin B1 | 1 | 2004 | 52 | 0.060 |
Why?
|
| Telomerase | 1 | 2009 | 730 | 0.060 |
Why?
|
| Cell-Free System | 1 | 2004 | 344 | 0.060 |
Why?
|
| Proteasome Endopeptidase Complex | 1 | 2011 | 1335 | 0.060 |
Why?
|
| Cyclin B | 1 | 2004 | 108 | 0.060 |
Why?
|
| Immunoenzyme Techniques | 1 | 2007 | 1799 | 0.060 |
Why?
|
| Histocompatibility Antigens | 1 | 2005 | 471 | 0.060 |
Why?
|
| Prefrontal Cortex | 1 | 2014 | 2147 | 0.060 |
Why?
|
| Autoimmunity | 3 | 2009 | 1350 | 0.060 |
Why?
|
| Trypsin | 1 | 2004 | 511 | 0.060 |
Why?
|
| Vaccines | 1 | 2013 | 823 | 0.060 |
Why?
|
| Muscle Cells | 1 | 2005 | 197 | 0.060 |
Why?
|
| Tumor Escape | 1 | 2007 | 350 | 0.060 |
Why?
|
| Dimerization | 1 | 2005 | 895 | 0.060 |
Why?
|
| Ploidies | 1 | 2004 | 281 | 0.060 |
Why?
|
| Bone Neoplasms | 1 | 2016 | 2530 | 0.060 |
Why?
|
| Glycolysis | 3 | 2005 | 829 | 0.060 |
Why?
|
| Adaptor Proteins, Signal Transducing | 1 | 2014 | 2917 | 0.060 |
Why?
|
| Transduction, Genetic | 1 | 2006 | 913 | 0.060 |
Why?
|
| Immunity | 2 | 2007 | 1014 | 0.060 |
Why?
|
| Time Factors | 12 | 2005 | 40075 | 0.060 |
Why?
|
| Phosphothreonine | 1 | 2003 | 63 | 0.060 |
Why?
|
| ATP-Binding Cassette Transporters | 1 | 2006 | 560 | 0.060 |
Why?
|
| Necrosis | 1 | 2007 | 1643 | 0.060 |
Why?
|
| Adenosine Triphosphatases | 1 | 2007 | 839 | 0.060 |
Why?
|
| Autoantigens | 1 | 2007 | 892 | 0.060 |
Why?
|
| Serpins | 1 | 2004 | 247 | 0.060 |
Why?
|
| Dichlororibofuranosylbenzimidazole | 2 | 1992 | 15 | 0.060 |
Why?
|
| Methylphenazonium Methosulfate | 1 | 2002 | 3 | 0.050 |
Why?
|
| Mitogen-Activated Protein Kinase 1 | 1 | 2004 | 489 | 0.050 |
Why?
|
| Casein Kinase II | 1 | 2003 | 128 | 0.050 |
Why?
|
| Cell Communication | 1 | 2010 | 1621 | 0.050 |
Why?
|
| Dementia | 1 | 2016 | 2518 | 0.050 |
Why?
|
| Pancreas | 1 | 2009 | 1687 | 0.050 |
Why?
|
| Bone Marrow Cells | 1 | 2010 | 2513 | 0.050 |
Why?
|
| Pancreatitis | 1 | 2009 | 1092 | 0.050 |
Why?
|
| Activities of Daily Living | 1 | 2011 | 2419 | 0.050 |
Why?
|
| Histone Deacetylase Inhibitors | 1 | 2007 | 789 | 0.050 |
Why?
|
| Gap Junctions | 2 | 2001 | 233 | 0.050 |
Why?
|
| Oligopeptides | 2 | 2002 | 1189 | 0.050 |
Why?
|
| Receptor, Macrophage Colony-Stimulating Factor | 1 | 2002 | 87 | 0.050 |
Why?
|
| Inositol 1,4,5-Trisphosphate | 3 | 1993 | 114 | 0.050 |
Why?
|
| Spectrometry, Fluorescence | 1 | 2004 | 688 | 0.050 |
Why?
|
| Tamoxifen | 1 | 2006 | 981 | 0.050 |
Why?
|
| MAP Kinase Kinase 1 | 1 | 2003 | 335 | 0.050 |
Why?
|
| RNA Interference | 1 | 2010 | 2890 | 0.050 |
Why?
|
| Interleukin-17 | 1 | 2007 | 901 | 0.050 |
Why?
|
| Immunosuppressive Agents | 2 | 2008 | 4153 | 0.050 |
Why?
|
| Phospholipases A2 | 2 | 1993 | 203 | 0.050 |
Why?
|
| Melanocytes | 1 | 2005 | 515 | 0.050 |
Why?
|
| Oxygen Consumption | 3 | 2005 | 1868 | 0.050 |
Why?
|
| Heteroduplex Analysis | 1 | 2000 | 8 | 0.050 |
Why?
|
| Mitosis | 2 | 2004 | 1208 | 0.050 |
Why?
|
| Chloramphenicol O-Acetyltransferase | 2 | 1999 | 222 | 0.050 |
Why?
|
| Sequence Homology, Amino Acid | 1 | 2005 | 2839 | 0.050 |
Why?
|
| Radiation, Ionizing | 2 | 2013 | 258 | 0.050 |
Why?
|
| Sarcoma, Experimental | 1 | 1980 | 128 | 0.050 |
Why?
|
| Cardiovascular Diseases | 1 | 2007 | 15160 | 0.050 |
Why?
|
| Cyclic AMP | 1 | 1985 | 1472 | 0.050 |
Why?
|
| Egtazic Acid | 1 | 2000 | 173 | 0.050 |
Why?
|
| Alanine | 1 | 2003 | 572 | 0.050 |
Why?
|
| Nucleic Acid Denaturation | 1 | 2000 | 111 | 0.050 |
Why?
|
| Mucin-1 | 3 | 2012 | 543 | 0.050 |
Why?
|
| Arsenicals | 1 | 2021 | 124 | 0.050 |
Why?
|
| Prostate | 2 | 2009 | 1775 | 0.050 |
Why?
|
| Active Transport, Cell Nucleus | 2 | 2016 | 443 | 0.050 |
Why?
|
| Mammary Glands, Animal | 2 | 2001 | 276 | 0.050 |
Why?
|
| Flavonoids | 1 | 2003 | 443 | 0.050 |
Why?
|
| Fatty Acids, Unsaturated | 1 | 2003 | 546 | 0.050 |
Why?
|
| Insulin | 3 | 1983 | 6582 | 0.050 |
Why?
|
| Antineoplastic Agents, Phytogenic | 1 | 2004 | 624 | 0.050 |
Why?
|
| Calcium-Calmodulin-Dependent Protein Kinase Type 2 | 1 | 2000 | 173 | 0.050 |
Why?
|
| Life Style | 1 | 2011 | 3835 | 0.040 |
Why?
|
| C-Reactive Protein | 1 | 2011 | 3778 | 0.040 |
Why?
|
| Calcineurin | 1 | 2000 | 226 | 0.040 |
Why?
|
| Neuroglia | 1 | 2005 | 928 | 0.040 |
Why?
|
| Immunization | 3 | 2013 | 1256 | 0.040 |
Why?
|
| CD4-Positive T-Lymphocytes | 3 | 2013 | 4386 | 0.040 |
Why?
|
| Flow Cytometry | 2 | 2013 | 5974 | 0.040 |
Why?
|
| Molecular Weight | 2 | 2008 | 2255 | 0.040 |
Why?
|
| Mitogens | 1 | 1999 | 232 | 0.040 |
Why?
|
| Interphase | 1 | 1999 | 226 | 0.040 |
Why?
|
| Adjuvants, Immunologic | 1 | 2005 | 1000 | 0.040 |
Why?
|
| Endotoxins | 1 | 2002 | 527 | 0.040 |
Why?
|
| Microscopy, Fluorescence | 2 | 2004 | 2700 | 0.040 |
Why?
|
| Epigenesis, Genetic | 1 | 2012 | 3646 | 0.040 |
Why?
|
| K562 Cells | 1 | 2001 | 635 | 0.040 |
Why?
|
| Chelating Agents | 1 | 2000 | 380 | 0.040 |
Why?
|
| Odds Ratio | 1 | 2011 | 9849 | 0.040 |
Why?
|
| Lac Operon | 1 | 1999 | 238 | 0.040 |
Why?
|
| Thrombin | 2 | 1993 | 598 | 0.040 |
Why?
|
| Protein Synthesis Inhibitors | 1 | 1999 | 192 | 0.040 |
Why?
|
| Models, Molecular | 1 | 2009 | 5451 | 0.040 |
Why?
|
| Carrier Proteins | 1 | 1992 | 5023 | 0.040 |
Why?
|
| Ovarian Neoplasms | 2 | 2018 | 4839 | 0.040 |
Why?
|
| Gene Expression Regulation, Enzymologic | 2 | 2000 | 1213 | 0.040 |
Why?
|
| Dinoprostone | 1 | 2001 | 601 | 0.040 |
Why?
|
| Misonidazole | 2 | 1989 | 34 | 0.040 |
Why?
|
| Protein Isoforms | 1 | 2003 | 1730 | 0.040 |
Why?
|
| Coculture Techniques | 2 | 2001 | 1341 | 0.040 |
Why?
|
| Protein Kinase C-alpha | 1 | 1998 | 112 | 0.040 |
Why?
|
| Sulfonamides | 1 | 2008 | 1940 | 0.040 |
Why?
|
| Antineoplastic Agents, Hormonal | 1 | 2006 | 1524 | 0.040 |
Why?
|
| Basic-Leucine Zipper Transcription Factors | 1 | 2018 | 154 | 0.040 |
Why?
|
| Cyclosporine | 1 | 2000 | 788 | 0.040 |
Why?
|
| Arsenic | 1 | 2021 | 328 | 0.040 |
Why?
|
| Sex Factors | 1 | 2011 | 10400 | 0.040 |
Why?
|
| Oxidation-Reduction | 2 | 1994 | 2184 | 0.040 |
Why?
|
| T-Lymphocytes, Regulatory | 2 | 2009 | 2988 | 0.040 |
Why?
|
| Biomedical Research | 1 | 2013 | 3309 | 0.040 |
Why?
|
| Trans-Activators | 1 | 2007 | 2926 | 0.040 |
Why?
|
| Hydrogen-Ion Concentration | 4 | 2008 | 2556 | 0.040 |
Why?
|
| Genetic Variation | 1 | 2013 | 6542 | 0.040 |
Why?
|
| Mice, Transgenic | 4 | 2013 | 9735 | 0.040 |
Why?
|
| Pyrazoles | 1 | 2008 | 1972 | 0.040 |
Why?
|
| Viral Proteins | 1 | 2004 | 1900 | 0.040 |
Why?
|
| Cattle | 1 | 2003 | 3922 | 0.040 |
Why?
|
| Tacrolimus | 1 | 2000 | 743 | 0.040 |
Why?
|
| Glucose | 2 | 2007 | 4398 | 0.040 |
Why?
|
| Logistic Models | 1 | 2011 | 13409 | 0.040 |
Why?
|
| Peptide Mapping | 1 | 1996 | 263 | 0.040 |
Why?
|
| Drug Evaluation, Preclinical | 1 | 2002 | 1375 | 0.040 |
Why?
|
| Urokinase-Type Plasminogen Activator | 1 | 1997 | 336 | 0.040 |
Why?
|
| Multigene Family | 2 | 1990 | 1102 | 0.040 |
Why?
|
| Transplantation, Heterologous | 1 | 2005 | 2383 | 0.040 |
Why?
|
| Congresses as Topic | 1 | 2021 | 764 | 0.030 |
Why?
|
| Muscle, Skeletal | 1 | 2011 | 4925 | 0.030 |
Why?
|
| Dioxoles | 1 | 2016 | 104 | 0.030 |
Why?
|
| Electrophoresis | 2 | 1993 | 240 | 0.030 |
Why?
|
| Consensus Sequence | 1 | 1996 | 378 | 0.030 |
Why?
|
| Hydroxyeicosatetraenoic Acids | 1 | 1996 | 226 | 0.030 |
Why?
|
| Oncogene Proteins | 1 | 2020 | 749 | 0.030 |
Why?
|
| Myocytes, Cardiac | 1 | 2005 | 1629 | 0.030 |
Why?
|
| Transforming Growth Factor beta2 | 1 | 2016 | 75 | 0.030 |
Why?
|
| Oligonucleotide Array Sequence Analysis | 1 | 2005 | 3921 | 0.030 |
Why?
|
| Alzheimer Disease | 1 | 2016 | 8038 | 0.030 |
Why?
|
| Cell Lineage | 1 | 2004 | 2504 | 0.030 |
Why?
|
| Intercellular Adhesion Molecule-1 | 1 | 1999 | 1159 | 0.030 |
Why?
|
| Lymphocytes | 2 | 2000 | 2617 | 0.030 |
Why?
|
| Age Factors | 1 | 2011 | 18373 | 0.030 |
Why?
|
| Spheroids, Cellular | 1 | 2016 | 351 | 0.030 |
Why?
|
| Genetic Vectors | 1 | 2004 | 3424 | 0.030 |
Why?
|
| Spleen | 1 | 2000 | 2362 | 0.030 |
Why?
|
| Side-Population Cells | 1 | 2013 | 12 | 0.030 |
Why?
|
| Hyperglycemia | 2 | 1980 | 1373 | 0.030 |
Why?
|
| STAT3 Transcription Factor | 1 | 2018 | 874 | 0.030 |
Why?
|
| COS Cells | 1 | 2016 | 1161 | 0.030 |
Why?
|
| Rats, Long-Evans | 1 | 2014 | 387 | 0.030 |
Why?
|
| Mammary Tumor Virus, Mouse | 1 | 2013 | 61 | 0.030 |
Why?
|
| Base Pairing | 1 | 2013 | 141 | 0.030 |
Why?
|
| Virulence Factors, Bordetella | 1 | 1993 | 156 | 0.030 |
Why?
|
| Pertussis Toxin | 1 | 1993 | 178 | 0.030 |
Why?
|
| Stimulation, Chemical | 1 | 1993 | 326 | 0.030 |
Why?
|
| Inhibitor of Apoptosis Proteins | 1 | 2014 | 215 | 0.030 |
Why?
|
| Gene Knockdown Techniques | 1 | 2018 | 1656 | 0.030 |
Why?
|
| Cyclin-Dependent Kinase Inhibitor p21 | 1 | 2014 | 365 | 0.030 |
Why?
|
| HCT116 Cells | 1 | 2014 | 409 | 0.030 |
Why?
|
| Regulatory Sequences, Nucleic Acid | 1 | 1997 | 794 | 0.030 |
Why?
|
| Ethers, Cyclic | 1 | 1992 | 33 | 0.030 |
Why?
|
| Retroviridae Infections | 1 | 2013 | 151 | 0.030 |
Why?
|
| Okadaic Acid | 1 | 1992 | 67 | 0.030 |
Why?
|
| Brefeldin A | 1 | 1992 | 72 | 0.030 |
Why?
|
| Interleukin-10 | 1 | 2018 | 1200 | 0.030 |
Why?
|
| Atherosclerosis | 1 | 2009 | 3444 | 0.030 |
Why?
|
| 1-(5-Isoquinolinesulfonyl)-2-Methylpiperazine | 1 | 1992 | 57 | 0.030 |
Why?
|
| Genistein | 1 | 1992 | 88 | 0.030 |
Why?
|
| Acetylcysteine | 1 | 1994 | 271 | 0.030 |
Why?
|
| Tunicamycin | 1 | 1992 | 112 | 0.030 |
Why?
|
| Drug Stability | 1 | 1992 | 291 | 0.030 |
Why?
|
| Heating | 1 | 1993 | 97 | 0.030 |
Why?
|
| Camptothecin | 2 | 1993 | 576 | 0.030 |
Why?
|
| Isoflavones | 1 | 1992 | 139 | 0.030 |
Why?
|
| Melanoma | 3 | 2005 | 5511 | 0.030 |
Why?
|
| Antigens, Polyomavirus Transforming | 1 | 2012 | 261 | 0.020 |
Why?
|
| Cathepsin D | 1 | 2011 | 61 | 0.020 |
Why?
|
| Galactosides | 1 | 2010 | 52 | 0.020 |
Why?
|
| Benzamides | 1 | 2016 | 1379 | 0.020 |
Why?
|
| Lung Neoplasms | 2 | 2013 | 13104 | 0.020 |
Why?
|
| Isoquinolines | 1 | 1992 | 366 | 0.020 |
Why?
|
| Phosphoproteins | 1 | 1999 | 2441 | 0.020 |
Why?
|
| Blood | 1 | 1993 | 598 | 0.020 |
Why?
|
| Receptors, Purinergic P2X7 | 1 | 2011 | 85 | 0.020 |
Why?
|
| Vitamin K | 1 | 1993 | 295 | 0.020 |
Why?
|
| Glioma | 1 | 2005 | 3401 | 0.020 |
Why?
|
| Tumor Virus Infections | 1 | 2013 | 454 | 0.020 |
Why?
|
| Bradykinin | 1 | 1989 | 214 | 0.020 |
Why?
|
| Restriction Mapping | 1 | 1990 | 878 | 0.020 |
Why?
|
| Phosphoric Diester Hydrolases | 1 | 1990 | 197 | 0.020 |
Why?
|
| Tunica Media | 1 | 2009 | 113 | 0.020 |
Why?
|
| Sequence Homology, Nucleic Acid | 1 | 1990 | 1085 | 0.020 |
Why?
|
| RNA, Small Interfering | 1 | 2018 | 3505 | 0.020 |
Why?
|
| Eukaryotic Initiation Factor-2 | 1 | 2009 | 190 | 0.020 |
Why?
|
| Genes | 1 | 1992 | 1893 | 0.020 |
Why?
|
| Membrane Potential, Mitochondrial | 1 | 2009 | 297 | 0.020 |
Why?
|
| Binding, Competitive | 1 | 1990 | 1157 | 0.020 |
Why?
|
| Mice, Inbred Strains | 1 | 1991 | 1828 | 0.020 |
Why?
|
| Nitroimidazoles | 1 | 1989 | 106 | 0.020 |
Why?
|
| Norepinephrine | 1 | 2011 | 909 | 0.020 |
Why?
|
| Caspases, Initiator | 1 | 2008 | 32 | 0.020 |
Why?
|
| Apoptosis Inducing Factor | 1 | 2008 | 55 | 0.020 |
Why?
|
| Cathepsin B | 1 | 2008 | 82 | 0.020 |
Why?
|
| Aminoquinolines | 1 | 1988 | 109 | 0.020 |
Why?
|
| Eicosanoids | 1 | 1989 | 279 | 0.020 |
Why?
|
| Transport Vesicles | 1 | 2008 | 83 | 0.020 |
Why?
|
| 3-O-Methylglucose | 1 | 1986 | 37 | 0.020 |
Why?
|
| Methylglucosides | 1 | 1986 | 36 | 0.020 |
Why?
|
| Kaplan-Meier Estimate | 1 | 2018 | 6539 | 0.020 |
Why?
|
| Indicators and Reagents | 1 | 1988 | 462 | 0.020 |
Why?
|
| Vacuoles | 1 | 2008 | 229 | 0.020 |
Why?
|
| Rubidium | 1 | 1986 | 133 | 0.020 |
Why?
|
| Histocompatibility Antigens Class I | 2 | 2004 | 1366 | 0.020 |
Why?
|
| Immunity, Active | 1 | 2006 | 60 | 0.020 |
Why?
|
| Forkhead Transcription Factors | 1 | 2014 | 1613 | 0.020 |
Why?
|
| Tunica Intima | 1 | 2009 | 464 | 0.020 |
Why?
|
| Biological Assay | 1 | 1990 | 652 | 0.020 |
Why?
|
| Cluster Analysis | 1 | 2013 | 2715 | 0.020 |
Why?
|
| Regional Blood Flow | 2 | 1980 | 1525 | 0.020 |
Why?
|
| Aged, 80 and over | 1 | 2011 | 57776 | 0.020 |
Why?
|
| Software | 1 | 2000 | 4441 | 0.020 |
Why?
|
| Surface-Active Agents | 1 | 1986 | 159 | 0.020 |
Why?
|
| Blood Glucose | 1 | 1980 | 6254 | 0.020 |
Why?
|
| Inositol | 1 | 1987 | 218 | 0.020 |
Why?
|
| Membrane Lipids | 1 | 1987 | 249 | 0.020 |
Why?
|
| Bucladesine | 1 | 1985 | 121 | 0.020 |
Why?
|
| Transcription Factor RelA | 1 | 2006 | 275 | 0.020 |
Why?
|
| Quinones | 1 | 2005 | 76 | 0.020 |
Why?
|
| DNA, Neoplasm | 1 | 1990 | 1758 | 0.020 |
Why?
|
| Phosphoric Monoester Hydrolases | 1 | 2006 | 431 | 0.020 |
Why?
|
| Protein Kinase Inhibitors | 1 | 2000 | 5534 | 0.020 |
Why?
|
| Benzoquinones | 1 | 2005 | 201 | 0.020 |
Why?
|
| Receptors, Adrenergic, beta | 1 | 2005 | 246 | 0.010 |
Why?
|
| Prognosis | 1 | 2005 | 29060 | 0.010 |
Why?
|
| Mathematics | 1 | 1985 | 728 | 0.010 |
Why?
|
| Guinea Pigs | 1 | 1985 | 1386 | 0.010 |
Why?
|
| Adenosine Monophosphate | 1 | 1985 | 275 | 0.010 |
Why?
|
| Pilot Projects | 1 | 2016 | 8319 | 0.010 |
Why?
|
| Lactams, Macrocyclic | 1 | 2005 | 320 | 0.010 |
Why?
|
| Monophenol Monooxygenase | 1 | 2002 | 69 | 0.010 |
Why?
|
| Mitochondrial Proteins | 1 | 2009 | 994 | 0.010 |
Why?
|
| Clone Cells | 2 | 2002 | 1692 | 0.010 |
Why?
|
| Microtubule-Associated Proteins | 1 | 2008 | 1085 | 0.010 |
Why?
|
| Myeloid Differentiation Factor 88 | 1 | 2006 | 571 | 0.010 |
Why?
|
| Interferon-gamma | 1 | 2011 | 3207 | 0.010 |
Why?
|
| Piperazines | 1 | 1992 | 2488 | 0.010 |
Why?
|
| Drug Synergism | 1 | 2006 | 1794 | 0.010 |
Why?
|
| Adoptive Transfer | 1 | 2004 | 844 | 0.010 |
Why?
|
| Culture Media | 1 | 1983 | 909 | 0.010 |
Why?
|
| Cell Line, Transformed | 1 | 2002 | 898 | 0.010 |
Why?
|
| Polymorphism, Single Nucleotide | 1 | 2000 | 15520 | 0.010 |
Why?
|
| Regression Analysis | 1 | 2011 | 6459 | 0.010 |
Why?
|
| 5' Untranslated Regions | 1 | 2001 | 249 | 0.010 |
Why?
|
| Tritium | 1 | 2001 | 745 | 0.010 |
Why?
|
| Biological Transport, Active | 1 | 1980 | 349 | 0.010 |
Why?
|
| Uridine | 1 | 2001 | 146 | 0.010 |
Why?
|
| Glucocorticoids | 1 | 1989 | 2108 | 0.010 |
Why?
|
| Macromolecular Substances | 1 | 2002 | 1454 | 0.010 |
Why?
|
| Connexin 43 | 1 | 2001 | 207 | 0.010 |
Why?
|
| Thymidine | 1 | 1980 | 310 | 0.010 |
Why?
|
| Mice, Inbred C3H | 1 | 2001 | 964 | 0.010 |
Why?
|
| Drug Resistance | 1 | 1985 | 1608 | 0.010 |
Why?
|
| Electrocoagulation | 1 | 1980 | 158 | 0.010 |
Why?
|
| Aged | 1 | 2011 | 163288 | 0.010 |
Why?
|
| Connexins | 1 | 2001 | 357 | 0.010 |
Why?
|
| Desmosomes | 1 | 1998 | 73 | 0.010 |
Why?
|
| I-kappa B Kinase | 1 | 1999 | 252 | 0.010 |
Why?
|
| Carcinoma, Pancreatic Ductal | 1 | 2009 | 1636 | 0.010 |
Why?
|
| Rodentia | 1 | 1980 | 261 | 0.010 |
Why?
|
| Biological Transport | 2 | 1995 | 2120 | 0.010 |
Why?
|
| Gamma Rays | 1 | 1998 | 320 | 0.010 |
Why?
|
| Receptors, Immunologic | 1 | 2002 | 1423 | 0.010 |
Why?
|
| Brain | 1 | 2003 | 26388 | 0.010 |
Why?
|
| Lymph Nodes | 1 | 2007 | 3476 | 0.010 |
Why?
|
| Tight Junctions | 1 | 1998 | 311 | 0.010 |
Why?
|
| Thymus Gland | 1 | 2001 | 1267 | 0.010 |
Why?
|
| Dogs | 1 | 2001 | 3912 | 0.010 |
Why?
|
| Spectrin | 1 | 1995 | 177 | 0.010 |
Why?
|
| Antibodies, Monoclonal | 1 | 1992 | 9274 | 0.010 |
Why?
|
| Muscles | 1 | 1979 | 1614 | 0.010 |
Why?
|
| Neoplasms, Experimental | 1 | 1980 | 1276 | 0.010 |
Why?
|
| Rats, Sprague-Dawley | 1 | 2005 | 8300 | 0.010 |
Why?
|
| Immunohistochemistry | 1 | 2007 | 11366 | 0.010 |
Why?
|
| Rabbits | 1 | 1980 | 4894 | 0.010 |
Why?
|
| Dactinomycin | 1 | 1993 | 318 | 0.010 |
Why?
|
| Pregnancy | 1 | 2014 | 29144 | 0.010 |
Why?
|
| Child | 1 | 2000 | 77709 | 0.010 |
Why?
|
| Cell Adhesion Molecules | 1 | 1998 | 1602 | 0.010 |
Why?
|
| Pancreatic Neoplasms | 1 | 2009 | 5263 | 0.010 |
Why?
|
| Transplantation, Homologous | 1 | 1980 | 4777 | 0.010 |
Why?
|
| Cell Adhesion | 1 | 1998 | 3144 | 0.010 |
Why?
|
| Disease Models, Animal | 1 | 2009 | 18034 | 0.010 |
Why?
|
| Electrophoresis, Gel, Two-Dimensional | 1 | 1990 | 280 | 0.010 |
Why?
|
| Etanidazole | 1 | 1989 | 26 | 0.010 |
Why?
|
| Leukemia, Erythroblastic, Acute | 1 | 1990 | 189 | 0.010 |
Why?
|
| Hypertension | 1 | 2009 | 8479 | 0.010 |
Why?
|
| Intermediate Filaments | 1 | 1989 | 175 | 0.010 |
Why?
|
| Adult | 2 | 2013 | 214052 | 0.000 |
Why?
|
| Methylation | 1 | 1990 | 1106 | 0.000 |
Why?
|
| Phosphatidic Acids | 1 | 1986 | 49 | 0.000 |
Why?
|
| Diglycerides | 1 | 1986 | 176 | 0.000 |
Why?
|
| Kidney | 1 | 2001 | 7184 | 0.000 |
Why?
|
| Methionine | 1 | 1987 | 590 | 0.000 |
Why?
|
| Rotenone | 1 | 1984 | 43 | 0.000 |
Why?
|
| Antibodies | 1 | 1993 | 2460 | 0.000 |
Why?
|
| Young Adult | 1 | 2011 | 56429 | 0.000 |
Why?
|
| Dextran Sulfate | 1 | 1984 | 236 | 0.000 |
Why?
|
| Liver | 1 | 1979 | 7475 | 0.000 |
Why?
|
| Microcirculation | 1 | 1988 | 1287 | 0.000 |
Why?
|
| Dose-Response Relationship, Radiation | 1 | 1984 | 876 | 0.000 |
Why?
|
| Radiotherapy | 1 | 1988 | 1533 | 0.000 |
Why?
|
| Axons | 1 | 1989 | 1685 | 0.000 |
Why?
|
| Cell Separation | 1 | 1983 | 1751 | 0.000 |
Why?
|
| Clinical Trials as Topic | 1 | 1988 | 7914 | 0.000 |
Why?
|
| Research Design | 1 | 1988 | 5984 | 0.000 |
Why?
|